facebook


Search

An app designed to help those living with Cystic Fibrosis manage their daily regimen

App Store

Google Play

Treatment Reminders

  • Set up treatment reminders for your medication or activity to focus on adherence with CF treatment regimens
  • Allows for full customization based on dosing frequency so that the app can deliver accurate reminders throughout the user’s day, week, month
  • View and edit your treatment tracking as required

TOBI Podhaler Resources

PodManagerTM app provides a library of educational content focused on towards the proper use of TOBI Podhaler.

View step-by-step video instructions on administration

  • How to prepare the first dose
  • Loading the capsule
  • Complete dosing and aftercare

Information for TOBI Podhaler patient support programs such as PodCare+ and Savings Card signup

Adherence Tracking and Analytics

  • Treatment tracking function allows the user to record each time they have taken a dose, completed a treatment, or finished an activity.
  • Adherence data compiled and displayed in graphs, calendar, and reports allows users to see proficiency with their overall CF treatment regimen.
  • Export data for PDF use or share your progress via social media.

Air Quality

Real-time air quality alerts deliver a convenient update about the current outside environment based on the user’s location

Air Quality Index measurements are based on hourly readings for your location.

Air Quality Index (AQI)

  • 0-50 implies that air quality is considered as good and pollution poses little or no risk
  • 51-100 implies that air quality is acceptable but poses a moderate health concern for people with respiratory disease.
  • 101-150 Members of sensitive groups may experience health effects. The general public is less likely to be affected.
  • 151-200 indicates that air quality is unhealthy and members of sensitive groups may experience more serious health effects
  • 201-300 & above indicates that it is very unhealthy and hazardous for everyone.

IMPORTANT SAFETY INFORMATION

INDICATION

TOBI® Podhaler® (Tobramycin Inhalation Powder) 28 mg per capsule is a prescription inhaled medication for cystic fibrosis patients whose lungs contain bacteria called Pseudomonas aeruginosa.

It is not known if TOBI Podhaler is safe and effective in patients under 6 years of age, in those with lung function outside of a certain range, or in those whose lungs contain bacteria called Burkholderia cepacia.

IMPORTANT SAFETY INFORMATION

Do not swallow TOBI Podhaler capsules. TOBI Podhaler capsules are used only with the Podhaler device and inhaled through your mouth (oral inhalation). Never place a capsule in the mouthpiece of the Podhaler device.

You should not use TOBI Podhaler if you are allergic to it or to any other aminoglycoside antibacterial medicines.

Tell your doctor before starting treatment all of your medical conditions, including if you have or have had hearing problems, dizziness, kidney problems, muscle weakness, breathing problems such as wheezing, coughing or chest tightness, if you had an organ transplant, are pregnant or nursing or plan to become pregnant or nurse.

TOBI Podhaler contains a medicine that can harm your unborn baby. It is not known if it passes into breast milk. Check your baby for watery stools, bloody stools, thrush or diaper rash if you breast feed.

Tell your doctor about all the medicines you take including over-the-counter medicines, vitamins, and herbal supplements. If you are using TOBI Podhaler, discuss if you should take other medicines that may harm your nervous system, kidneys, or hearing; "water pills" (diuretics) such as Edecrin® (ethacrynic acid), Lasix® (furosemide), or intravenous mannitol; urea.

TOBI Podhaler can cause serious side effects, including:

Severe breathing problems (bronchospasm). Tell your doctor right away if you get shortness of breath with wheezing or coughing and chest tightness while using TOBI Podhaler.

Hearing loss or ringing in the ears (ototoxicity). Tell your doctor right away if you have hearing loss, noises in your ears such as ringing or hissing, vertigo, difficulty with balance, or dizziness.

Worsening kidney problems (nephrotoxicity). TOBI Podhaler is in a class of medicines that may cause worsening kidney problems, especially in people with known or suspected kidney problems. Your healthcare provider may do a blood test to check how your kidneys are working while you are using TOBI Podhaler.

Worsening muscle weakness. TOBI Podhaler is in a class of medicines that can cause worsening muscle weakness in people who already have problems with muscle weakness (myasthenia gravis or Parkinson's disease).

TOBI Podhaler is in a class of medicines which may cause harm to an unborn baby.

The most common side effects of TOBI Podhaler include cough, worsening of lung problems or cystic fibrosis, productive cough, shortness of breath, fever, sore throat, changes in your voice (hoarseness), coughing up blood, and headache.

Let your doctor know if your symptoms worsen or if you have a side effect that bothers you enough to stop treatment or that does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information and Patient Product Information.


TOBI, PODHALER, the TOBI Logo and PODCARE+ are registered trademarks of BGP Products Operations GmbH, a Viatris Company.

PODMANAGER is a trademark of BGP Products Operations GmbH, a Viatris Company.


PULMOSPHERE is a registered trademark of Novartis AG, licensed to the Viatris Companies.


VIATRIS is a trademark of Mylan Inc., a Viatris Company.


All other product names and registered trademarks are property of their respective owners.

Use of website is governed by the Terms of Use and Privacy Notice.

© 2021 Viatris Inc. All Rights Reserved.

Cookie Notice | California Supplemental Disclosure | Site Map | Contact Us

TOBI-2020-0224 V3